vascular disrupting agent

Related by string. vascular disrupting agents * VASCULAR . Vascular : cardio vascular . peripheral vascular disease . peripheral vascular / Disrupting . Disrupts . Disrupted : endocrine disrupting compounds . rainforests disrupt . severely disrupted / agenting . Agents : agent Scott Boras . Border Patrol agents * Tumour Vascular Disrupting Agent . vascular disrupting agents VDAs *

Related by context. All words. (Click for frequent words.) 75 signal transduction inhibitor 73 investigational humanized monoclonal antibody 73 OXi# 73 Tyrima 73 Hsp# Inhibitor 73 anticancer compound 73 angiogenesis inhibitor 73 receptor tyrosine kinase inhibitor 72 oxidative stress inducer 72 obatoclax 72 metaglidasen 72 Annamycin 72 proteasome inhibitor 72 tumor vascular disrupting 72 Xanafide 72 vascular disrupting agents 72 fosbretabulin 72 Archexin 72 mitogen activated ERK kinase 71 radiation sensitizer 71 ENMD # 71 seliciclib CYC# 71 liposomal formulation 71 Ceflatonin 71 CYT# potent vascular disrupting 71 alvespimycin 71 oral prodrug 71 CA4P 71 PDE4 inhibitor 71 phase IIb clinical 71 AEG# 71 orally bioavailable 71 Carfilzomib 71 entinostat 71 mertansine 71 Safinamide 71 protein kinase inhibitor 71 tyrosine kinase inhibitor 70 CBLC# 70 anticancer agent 70 Aplidin 70 histone deacetylase HDAC inhibitor 70 PSN# [002] 70 BNC# 70 MEK inhibitor 70 Voreloxin 70 ganetespib 70 Mipomersen 70 HuMax EGFr 70 ON #.Na 70 CCX# 70 Atiprimod 70 pan HDAC inhibitor 70 YONDELIS 70 selective kinase inhibitor 70 novel VDA molecule 69 MEK inhibitors 69 multi kinase inhibitor 69 vidofludimus 69 Phase Ib study 69 HuLuc# 69 Tumour Vascular Disrupting Agent 69 riociguat 69 Ceflatonin R 69 Amrubicin 69 highly selective inhibitor 69 Squalamine 69 pertuzumab 69 TRO# 69 Dasatinib 69 Hsp# inhibitor 69 CYC# 69 sodium glucose cotransporter 69 kinase inhibitor 69 BAL# [001] 69 ATL# [001] 69 mTOR inhibitor 69 anti amnesic 69 Lu AA# 69 Tarvacin TM 69 small molecule tyrosine 69 AKT inhibitor 69 BAY #-# 69 IAP inhibitor 69 CDK inhibitor 69 OMP #M# 69 vinca alkaloid 69 PEG SN# 69 kinase inhibition 69 proteasome inhibitors 69 OncoVEX GM CSF 69 Phase Ib clinical 69 Omacetaxine 69 JAK inhibitor 69 generation purine nucleoside 69 PCK# 69 histone deacetylase inhibitor 69 FOLOTYN ® 69 Guanilib 69 ATL/TV# 69 Azedra 69 Perifosine 68 Onconase 68 PI3K/mTOR 68 JAK1 68 HGS# 68 Symadex 68 somatostatin analogue 68 IMA# 68 small molecule Hedgehog 68 AP# [003] 68 Tanespimycin 68 small molecule inhibitor 68 GMX# 68 selective inhibitor 68 XmAb# 68 BRAF inhibitor 68 Virulizin ® 68 preclinically 68 PNP inhibitor 68 PRT# 68 virus HCV protease inhibitor 68 Elesclomol 68 novel anticancer 68 molecularly targeted 68 insulin sensitizer 68 therapeutic monoclonal antibody 68 investigational hepatitis C 68 Sym# 68 targeted radiotherapeutic 68 anti angiogenic 68 imatinib Gleevec ® 68 phase IIa clinical 68 PXD# 68 LHRH antagonists 68 HQK 68 humanized monoclonal antibody 68 HCV protease 68 nucleoside analog 68 Bruton tyrosine kinase Btk 68 CG# [003] 68 HSP# inhibitor 68 Dapagliflozin 68 R roscovitine 68 Talabostat 68 orally administered inhibitor 68 selective androgen receptor modulator 68 Cloretazine ® 68 JAK2 inhibitor 68 ALN TTR 68 Sphingomab 68 SNT MC# 68 tanespimycin 68 antibody MT# 68 immunomodulating 68 HCV protease inhibitors 68 Seliciclib 68 Azixa 68 YONDELIS R 68 regorafenib 68 tiapamil 68 SERMs 68 neuroprotectant 68 selective modulator 68 favorable pharmacokinetic profile 68 Blinatumomab 68 Tesetaxel 68 DXL# 67 TBC# 67 trastuzumab DM1 67 selective inhibition 67 triphendiol 67 Aurora kinase 67 MEK inhibitor RDEA# 67 Panzem R 67 CEQ# 67 CCR5 antagonist 67 vemurafenib 67 evaluating tivozanib 67 Traficet EN 67 PI3K inhibitor 67 Sapacitabine 67 potent anticancer 67 BRIM2 67 preclinical efficacy 67 ADP receptor antagonist 67 Gleevec resistant 67 investigational pan BCR 67 erlotinib Tarceva ® 67 epothilone 67 immunomodulatory 67 SCH # 67 NXL# 67 immunotherapeutic agent 67 cediranib 67 non nucleoside inhibitor 67 Pertuzumab 67 TLR8 agonist 67 targeting CD# 67 Enzastaurin 67 Deforolimus 67 HCV protease inhibitor 67 Cloretazine R 67 INCB# [001] 67 axitinib 67 PARP inhibitor 67 Aurora Kinase 67 Tarvacin 67 PI3K/Akt pathway inhibitor 67 Aflibercept 67 small molecule glucokinase 67 chemopreventive agent 67 BN# [002] 67 Factor VIIa 67 GW# [003] 67 Angiocept 67 IgG1 antibody 67 Bortezomib 67 Fx #A 67 R#/MEM # 67 epigenetic therapies 67 HCV NS5B polymerase 67 EndoTAG TM -1 67 novel oral anticoagulant 67 Zybrestat 67 Hsp# inhibitors 67 antisense oligonucleotide 67 Anticalin R 67 TMC# [002] 67 Debio 67 MKC# MKC# PP 67 compound AEZS 67 combretastatin A4 phosphate CA4P 67 GRN# 67 Tasimelteon 67 tafamidis 67 Curaxins 67 Anavex #-# 67 Ambrisentan 67 Radezolid 67 RhuDex ® 67 Personalized Immunotherapy 66 Nanobody 66 ocular formulation 66 MAP# 66 HGS ETR2 66 Akt inhibitor 66 2 methoxyestradiol 66 antiproliferative effects 66 torezolid 66 antiangiogenic agent 66 depsipeptide 66 Hsp# inhibition 66 immunomodulator 66 PEGylated interferon 66 polymerase inhibitor 66 renin inhibitors 66 Denufosol 66 delafloxacin 66 isoform selective 66 Afatinib 66 CCR9 antagonist 66 Golimumab 66 selective antagonist 66 APOPTONE 66 tezampanel 66 elesclomol 66 lorvotuzumab mertansine 66 histone deacetylase inhibitors 66 multitargeted 66 compound perifosine 66 anticancer agents 66 molecular imaging radiopharmaceutical 66 mGluR2 NAM 66 vascular disrupting 66 CYT# 66 Phase #b/#a clinical 66 Phase #b/#a trial 66 phase IIb trial 66 Curaxin CBLC# 66 Zolinza 66 modulator SERM 66 MAGE A3 ASCI 66 potent antiproliferative 66 novel peptide 66 investigational compound 66 TH# [003] 66 peripherally acting 66 Phase Ib II 66 BIBW 66 HDACi 66 OncoVex 66 Romidepsin 66 bevacizumab Avastin ® 66 romidepsin 66 antiangiogenic activity 66 Pathway Inhibitor 66 Vilazodone 66 Quinamed 66 ospemifene 66 antitumor 66 Nexavar ® 66 rNAPc2 66 Hedgehog signaling pathway 66 FGFR 66 BZL# 66 Cloretazine 66 CRLX# 66 Curaxin 66 BAL# [002] 66 topoisomerase II inhibitor 66 Pimavanserin 66 Apoptone 66 elacytarabine 66 Nanobody ® 66 generation Hsp# inhibitor 66 Bruton tyrosine kinase 66 NVA# 66 PLX# 66 oral Azacitidine 66 Temsirolimus 66 GLYX 66 volociximab 66 CTAP# Capsules 66 reversible inhibitor 66 pomalidomide 66 GV# [001] 66 ASONEP 66 Panzem R NCD 66 RH1 66 Alzhemed TM 66 tubulin inhibitor 66 CLORETAZINE TM VNP#M 66 IRX 2 66 dasatinib Sprycel 66 Abiraterone acetate 66 trodusquemine 66 indibulin 66 TPI ASM8 66 humanized monoclonal 66 TRV# [001] 66 PTP 1B 66 rALLy clinical trial 66 PI3 kinase 66 torezolid phosphate 66 chemotherapeutic drug 66 HuMax CD4 66 induces apoptosis 66 LPA1 receptor 66 anti fibrotic 66 protein tyrosine phosphatase 1B 66 refractory chronic lymphocytic 66 forodesine 66 Elagolix 66 Panzem 66 CORT # 66 humanized anti 66 Irinotecan 66 IAP inhibitors 66 aurora kinase 66 PSMA ADC 65 VA# [002] 65 talabostat 65 Naproxcinod 65 LHRH antagonist 65 Angiolix 65 paclitaxel poliglumex 65 bortezomib Velcade ® 65 GLP toxicology studies 65 anti angiogenic agent 65 personalized immunotherapy 65 PrevOnco ™ 65 Aliskiren 65 cytostatic 65 RGB # 65 Vidofludimus 65 Degarelix 65 DB# [003] 65 Phase 1a clinical 65 antibody MAb 65 Pyridorin 65 Pazopanib 65 cMET 65 leading oral taxane 65 Cannabinor 65 metastatic renal cell carcinoma 65 peptibody 65 Exherin TM 65 Proxinium TM 65 IMC A# 65 EGS# 65 Anticalin 65 selective orally bioavailable 65 VEGF receptor 65 Iluvien ® 65 lumiliximab 65 TG# [003] 65 receptor inhibitor 65 multicenter Phase II 65 alpha antagonist 65 ANG# 65 novel prodrug 65 corticosteroid dexamethasone 65 oral proteasome inhibitor 65 CCR2 65 multikinase inhibitor 65 antisense drug 65 trabectedin 65 cetuximab Erbitux ® 65 anti CD3 65 Microplasmin 65 GRN#L 65 TREANDA 65 nanopharmaceutical 65 dasatinib Sprycel ® 65 relapsed multiple myeloma 65 AAG geldanamycin analog 65 DACH platinum 65 leukemia AML 65 NS#/#A protease 65 oncolytic vaccine 65 mapatumumab 65 maturation inhibitor 65 HGS ETR1 65 IMPDH inhibitor 65 acetonide FA 65 HDAC inhibitors 65 BRAF inhibitors 65 Glufosfamide 65 novel histone deacetylase 65 Aplidin R 65 solithromycin 65 Intravenous CP 65 ZK EPO 65 Laquinimod 65 alpha folate receptor 65 IMiDs R 65 TriRima 65 VEGF inhibitors 65 INT# [002] 65 seliciclib 65 inhibit metastasis 65 sorafenib Nexavar 65 AS# amonafide L malate 65 investigational HCV polymerase 65 humanised antibody 65 insulin sensitizers 65 PD LID 65 Luteinizing Hormone Releasing Hormone 65 Interferon alpha 65 phosphate S1P 65 ARIKACE ™ 65 registrational 65 Gefitinib 65 mGluR5 negative 65 siRNA therapeutics 65 sunitinib malate 65 NPC 1C 65 DNA intercalator 65 IL# PE#QQR 65 OncoVEX 65 SAR# [004] 65 ZYBRESTAT 65 LymphoStat B belimumab 65 atacicept 65 sapacitabine 65 EGFR TKI 65 OMNARIS HFA 65 potent inhibitor 65 immunotherapeutic 65 Cyclooxygenase Inhibiting Nitric Oxide 65 Bicifadine 65 Marqibo TM 65 candidate deforolimus 65 protein kinase inhibitors 65 PEGylated interferon beta 1a 65 Serdaxin ® 65 Zalypsis 65 PI3 kinase inhibitors 65 anti leukemic 65 BiTE R 65 Vidaza azacitidine 65 NTx TM -# 65 Elvitegravir 65 Ozarelix 65 dexpramipexole 65 SARMs 65 PSN# [001] 65 OvaRex R 65 Kinase Inhibitor 65 Cetrorelix 65 GeneICE 65 phase Ib 65 ThermoDox R 65 randomized controlled Phase 65 Combination REOLYSIN R 65 HCV polymerase inhibitors 65 PHX# 65 Serdaxin 65 Triapine 65 alkylating agent 65 SAR# [002] 65 Janus Kinase 65 Darinaparsin 65 mTOR inhibitors 64 Alpharadin 64 Pralatrexate 64 SYN# 64 exon skipping 64 Tezampanel 64 targeted antifolate 64 Aviptadil 64 Cloretazine VNP#M 64 IMC #B 64 SU# [003] 64 EGFR tyrosine kinase inhibitor 64 PARP inhibitors 64 OMAPRO 64 antitumoral 64 acyclovir Lauriad R 64 nilotinib Tasigna ® 64 histone deacetylase HDAC 64 cathepsin K inhibitor 64 LUX Lung 64 MKC# MT 64 VitiGam 64 BiTE 64 Dalbavancin 64 TLR9 agonist 64 LY# [003] 64 phosphatidylserine PS targeting 64 docetaxel Taxotere ® 64 chemokine receptor 64 CRMD# 64 Janus kinase 64 novel topoisomerase 64 VNP#M 64 apoptosis proteins 64 Hedgehog Pathway Inhibitor 64 selective serotonin 2C receptor 64 Clevudine 64 Solazed TM 64 PKC# 64 EGF receptor 64 oral antiviral 64 Epothilones 64 Preclinical studies suggest 64 TACI Ig 64 ABL inhibitor 64 cilengitide 64 HDAC Inhibitor 64 poly ADP ribose polymerase 64 EP #R 64 Spiegelmer ® 64 ALS #-# 64 Maraviroc 64 PrevOnco 64 antisense inhibitors 64 lapatinib Tykerb 64 investigational monoclonal antibody 64 histone deacetylase HDAC inhibitors 64 Panzem NCD 64 p# inhibitor 64 immune modulating 64 Silodosin 64 apoptosis inducer 64 huC# DM4 64 peptidic compound 64 5 HT6 receptor 64 registrational trial 64 CD# monoclonal antibody 64 #ME# 64 iSONEP 64 demonstrated antitumor activity 64 radezolid 64 thymalfasin 64 ongoing Phase 1b 64 Pirfenidone 64 ZYBRESTAT fosbretabulin 64 Nexavar sorafenib 64 peptidomimetic 64 LymphoStat B TM 64 KRN# 64 TG# [001] 64 Vernakalant 64 Phenoptin 64 2 inhibitor CYT# 64 Fleximer 64 Preclinical studies 64 next generation URAT1 64 ixabepilone 64 Trofex 64 OncoGel 64 Tarceva TM 64 elotuzumab 64 Liposomal 64 selective agonist 64 neuroprotective properties 64 ZYBRESTAT TM 64 EGFr 64 olaparib 64 antiapoptotic 64 rxRNA 64 Factor Receptor 64 antisense inhibitor 64 Imprime PGG 64 vosaroxin 64 ALGRX 64 glucokinase activator 64 telomerase therapeutic 64 thalidomide Thalomid 64 Pharmacokinetics PK 64 kidney urologic 64 Eribulin 64 ProSavin 64 ARRY # 64 Tumor Necrosis Factor 64 Fodosine 64 Muraglitazar 64 Belimumab 64 Kamada AAT 64 polymerase inhibitors 64 eltrombopag 64 immunotherapeutics 64 Catena ® 64 tranilast 64 somatostatin analog 64 EGFR inhibitors 64 disease modifying 64 antiangiogenesis 64 farletuzumab 64 Phase IIa clinical 64 VEGF inhibitor 64 AMN# [001] 64 RP# [002] 64 IMiD 64 antithrombotic 64 OHR/AVR# 64 Cloretazine R VNP#M 64 gemcitabine Gemzar ® 64 PDX pralatrexate 64 peptide conjugated 64 TRC# 64 AQ4N 64 taxane derivative 64 Vandetanib 64 ALN TTR# 64 Daclizumab 64 secretory phospholipase A2 sPLA2 64 anticancer therapeutics 64 DP b# 64 Sphingomab TM 64 MLN# 64 Aurora kinase inhibitors 64 Darusentan 64 Protein Kinase C 64 Maribavir 64 humanized antibody 64 INCB# [002] 64 huN# DM1 64 small molecule activator 64 bortezomib Velcade 64 glucagon receptor 64 Alfacell proprietary ribonuclease 64 gastrointestinal stromal tumors GIST 64 Icatibant 64 novel synthetic peptide 64 docetaxel Taxotere R 64 JAK#/JAK# 64 TELINTRA 64 tyrosine kinase inhibitors 64 Erlotinib 64 ALK inhibitor 64 SUTENT ® 64 afamelanotide 64 teriflunomide 64 neratinib 64 retapamulin 64 IL #E 64 Lodotra TM 64 LibiGel ® 64 anticoagulant reversing agent 64 enzastaurin 64 PEGylated Fab fragment 64 potent anti angiogenic 64 phase IIb study 64 Receptor Antagonist 64 omacetaxine mepesuccinate 64 sorafenib tablets 64 small molecule thrombopoietin 64 Bendavia 64 Thiarabine 64 vorinostat 64 Plicera 64 EOquin TM 64 Ophena TM 64 anticancer activity 64 hypoxia activated prodrug 64 cytoprotective 64 MGd 64 drug ISA# 64 generation proteasome inhibitor 64 mTOR kinase 64 nilotinib Tasigna 64 Fc fusion protein 64 Epratuzumab 64 epothilones 64 nucleotide analog 64 Presents Preclinical Data 64 ART# 64 SPC# [001] 64 ELACYT 64 SGLT Inhibitors 64 vivo validation 64 sunitinib Sutent ® 64 partial agonist 64 KNS # 64 mTOR mammalian target 64 class mGluR5 inhibitor 63 AZILECT ® 63 DPP4 inhibitor 63 RNAi therapeutic targeting 63 SUCCEED trial 63 cancer immunotherapies 63 reslizumab 63 deforolimus 63 non nucleoside 63 TLR9 agonists 63 systemically administered 63 Lixivaptan 63 resolvin 63 Troxatyl 63 histamine dihydrochloride 63 acadesine 63 Exelixis compounds 63 siRNA therapeutic 63 highly selective endothelin 63 phase IIb 63 chimeric monoclonal antibody 63 inhibits protein synthesis 63 recurrent glioblastoma multiforme 63 ThermoDox ® 63 antitumor effects 63 IMiDs ® 63 investigational oral 63 renin inhibitor 63 potently inhibit 63 synthetic retinoid 63 castrate resistant prostate cancer 63 BMS # 63 trabedersen 63 Anticalin ® 63 zanolimumab 63 Phase #b/#a 63 cyclin dependent kinase inhibitor 63 Bavituximab 63 novel immunomodulatory 63 oral Factor Xa 63 PROVENGE sipuleucel T 63 oncolytic 63 VEGFR2 inhibitor 63 drug GAP #B# 63 Removab 63 HER2 positive metastatic breast 63 CR# vcMMAE 63 CGEN # 63 crizotinib PF # 63 alpha7 63 Ofatumumab 63 Vidaza R 63 GAP #B# 63 AACR NCI EORTC 63 BRIM3 63 Evoltra ® 63 amrubicin 63 inhibitor RG# 63 Diabetic Macular Edema DME 63 EOquin 63 candidate CRLX# 63 accumulate preferentially 63 Vorinostat 63 HIV integrase inhibitors 63 phase 2a 63 pro apoptotic 63 ZD# [001] 63 EGFR HER2 63 retaspimycin 63 developing Bicifadine serotonin 63 Phase IIb clinical trials 63 CCX# B 63 Bevirimat 63 CD# antibody [001] 63 PEGylated 63 Orally administered 63 non nucleoside HCV 63 ASA# 63 immunomodulatory therapy 63 selective inhibitors 63 SRT# [003] 63 otelixizumab 63 agent VDA 63 PDGF receptor 63 luteinizing hormone releasing 63 potent inhibition 63 leukotriene pathway 63 CD4 monoclonal antibody 63 Aurexis 63 PEGylated anti 63 BCR ABL inhibitors 63 Zoraxel 63 novel nucleoside analog 63 Campath ® 63 refractory AML 63 vaccine GRNVAC1 63 thymidylate synthase TS 63 allosteric modulator NAM 63 triggers apoptosis programmed 63 humanised monoclonal antibody 63 ZOLINZA 63 FK# 63 generation nucleoside analog 63 refractory acute myeloid 63 alagebrium 63 peroxisome proliferator activated 63 phase IIa 63 allosteric modulator 63 pharmacodynamic properties 63 THR beta agonist 63 proteasome inhibitor bortezomib 63 Onalta ™ 63 relapsed refractory multiple myeloma 63 Teriflunomide 63 LBH# 63 MT#/MEDI-# 63 selective inverse agonist 63 ILUVIEN ® 63 deacetylase inhibitors 63 AVN# [001] 63 Junovan TM 63 small molecule defensin 63 long acting muscarinic 63 varespladib 63 ENMD 63 #I TM# 63 androgen receptor antagonist 63 Bezielle 63 VEGFR2 63 TLK# 63 potent topoisomerase II 63 Apaziquone 63 TRIOLEX 63 Lubiprostone 63 immune modulatory 63 Bucindolol 63 chemically modified siRNA 63 Omacetaxine mepesuccinate 63 photoprotective drug 63 RhuDex R 63 ZACTIMA 63 LE SN# 63 pharmacological chaperone 63 Onalta 63 Bevacizumab 63 palifosfamide 63 Phase 2a trial 63 Tolvaptan 63 fatty acid amide hydrolase 63 selective estrogen receptor 63 Pradefovir 63 monoclonal antibody MAb 63 cangrelor 63 NEUGENE 63 MDV# 63 mda 7 63 JAK#/JAK# inhibitor CYT# 63 relapsed leukemia 63 anti angiogenic therapy 63 AIR# [001] 63 cytokine refractory 63 hypoxia selective 63 Oxytrex TM 63 orally dosed 63 OX1 63 anti angiogenic drugs 63 PI3K Akt 63 eprotirome 63 Zoraxel TM 63 NS5A 63 Phase #/#a trial 63 TAFA# 63 oral picoplatin 63 JAK inhibitors 63 Abiraterone 63 eniluracil 63 Stapled Peptide 63 VDAs 63 Allovectin 7 63 antiangiogenic 63 Phase Ib clinical trials 63 immune modulator 63 Aurora kinase inhibitor 63 Presents Preclinical 63 ALN PCS 63 Randomized Phase 63 ara C 63 pharmacokinetic PK study 63 midstage trials 63 samalizumab 63 protein mTOR 63 antitumor activity 63 MET amplification 63 Pemetrexed 63 Elotuzumab 63 Pentraxin 2 63 VEGF receptor inhibitor 63 Tyrosine Kinase Inhibitor 63 ATL# [002] 63 DermaVir Patch 63 SCIB1 63 Bosutinib 63 TLR7 63 TKB# 63 Posiphen 63 elvitegravir 63 BrachySil TM 63 ZFP Therapeutic 63 Eniluracil 63 cetuximab Erbitux R 63 EZN 63 Herceptin trastuzumab 63 receptor partial agonist 63 Lenalidomide 63 CIMZIA TM 63 oral ridaforolimus 63 oral JAK1 63 Telatinib 63 Angiolix R 63 Methylnaltrexone 63 TLR antagonists 63 telomerase inhibitor 63 M2 subunit 63 HDAC inhibitor 63 Oral NKTR 63 fibrotic disease 63 orally inhaled migraine 63 Exelixis XL# 63 Everolimus 63 Chemophase 63 flavopiridol 63 Phase 1b clinical 63 Pivotal Phase III 63 LEP ETU 63 MT# MEDI 63 metastatic colorectal 63 bioactive lipids 63 paclitaxel Taxol 63 BiTE antibody 63 relapsed MCL 63 TNF alpha inhibitor 63 TNF Tumor Necrosis Factor 63 cannabinor 63 Lacosamide 62 BGC# 62 induce apoptosis 62 cleavable linker 62 MET VEGFR2 62 ularitide 62 visilizumab 62 anti secretory 62 histone deacetylase 62 mGlu2 3 62 Locked Nucleic Acid LNA 62 trastuzumab DM1 T DM1 62 targeting PCSK9 62 trastuzumab Herceptin 62 Trastuzumab 62 dirucotide 62 ruxolitinib 62 OvaRex ® MAb 62 anti mitotic 62 viral kinetics 62 EKC Cide 62 enzyme inhibitor 62 receptor agonists 62 Litx 62 NP2 Enkephalin 62 TRX1 62 relapsing remitting multiple sclerosis 62 Nimotuzumab 62 RNAi Therapeutic 62 Desmoteplase 62 Lenocta 62 small molecule activators 62 Meets Primary Endpoint 62 ISIS # 62 PS# [001] 62 gamma secretase inhibitor 62 Vicriviroc 62 Lisofylline LSF

Back to home page